H19 and cholangiocarcinoma: In CCA cells, H19 promoted proliferation, migration, and invasion, acting on different targets: it increased Bcl-2 expression via miR-216 downregulation [83], induced inflammatory mediators, particularly IL-6, sponging let-7a/let-7b [84], and enhanced EMT markers [85].